Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tareq Saleh

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Cell Cycle (Georgetown, Tex.)|June 16, 2024
Therapy-induced senescence is finally escapable, what is next?Tareq Saleh
Cancer Metastasis Reviews|January 21, 2023
Insights into the role of senescence in tumor dormancy: mechanisms and applicationsValerie J DeLuca, Tareq Saleh
British Journal of Cancer|March 19, 2022
Considering therapy-induced senescence as a mechanism of tumour dormancy contributing to disease recurrenceTareq Saleh, David A Gewirtz
Molecular Pharmacology|September 21, 2021
Potential Use of Senolytics for Pharmacological Targeting of Precancerous LesionsTareq Saleh, Valerie J Carpenter
Biochimica Et Biophysica Acta|June 19, 2016
Autophagy is not uniformly cytoprotective: a personalized medicine approach for autophagy inhibition as a therapeutic strategy in non-small cell lung cancerTareq Saleh, Laurie Cuttino, David A Gewirtz
Cancer Research|February 27, 2019
Tumor Cell Escape from Therapy-Induced Senescence as a Model of Disease Recurrence after DormancyTareq Saleh, Liliya Tyutyunyk-Massey, David A Gewirtz
Cancers|February 13, 2021
Senolytics for Cancer Therapy: Is All That Glitters Really Gold?Valerie J Carpenter, Tareq Saleh, David A Gewirtz
Ageing Research Reviews|September 12, 2025
Potential connections between senescence and chemobrain: An early overview of literatureNebras Melhem, Shahd Qutifan, Mohammad Alsalem, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|October 8, 2023
Therapy-induced senescence as a component of tumor biology: Evidence from clinical cancerTareq Saleh, Sarah Bloukh, Mira Hasan, et al.
Journal of Clinical Medicine|March 28, 2026
Disproportionality Analysis of Hematologic Adverse Event Signals Associated with Venetoclax in Combination with Senescence-Inducing ChemotherapyTareq Saleh, Mohannad Ramadan, Anoud Alsoud, et al.
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Cell Cycle (Georgetown, Tex.)|June 16, 2024
Therapy-induced senescence is finally escapable, what is next?Tareq Saleh
Cancer Metastasis Reviews|January 21, 2023
Insights into the role of senescence in tumor dormancy: mechanisms and applicationsValerie J DeLuca, Tareq Saleh
British Journal of Cancer|March 19, 2022
Considering therapy-induced senescence as a mechanism of tumour dormancy contributing to disease recurrenceTareq Saleh, David A Gewirtz
Molecular Pharmacology|September 21, 2021
Potential Use of Senolytics for Pharmacological Targeting of Precancerous LesionsTareq Saleh, Valerie J Carpenter
Biochimica Et Biophysica Acta|June 19, 2016
Autophagy is not uniformly cytoprotective: a personalized medicine approach for autophagy inhibition as a therapeutic strategy in non-small cell lung cancerTareq Saleh, Laurie Cuttino, David A Gewirtz
Cancer Research|February 27, 2019
Tumor Cell Escape from Therapy-Induced Senescence as a Model of Disease Recurrence after DormancyTareq Saleh, Liliya Tyutyunyk-Massey, David A Gewirtz
Cancers|February 13, 2021
Senolytics for Cancer Therapy: Is All That Glitters Really Gold?Valerie J Carpenter, Tareq Saleh, David A Gewirtz
Ageing Research Reviews|September 12, 2025
Potential connections between senescence and chemobrain: An early overview of literatureNebras Melhem, Shahd Qutifan, Mohammad Alsalem, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|October 8, 2023
Therapy-induced senescence as a component of tumor biology: Evidence from clinical cancerTareq Saleh, Sarah Bloukh, Mira Hasan, et al.
Journal of Clinical Medicine|March 28, 2026
Disproportionality Analysis of Hematologic Adverse Event Signals Associated with Venetoclax in Combination with Senescence-Inducing ChemotherapyTareq Saleh, Mohannad Ramadan, Anoud Alsoud, et al.
Pageof 9